These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 7678774)

  • 1. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
    Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
    Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
    Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
    Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
    Ghatak S; Oliveria P; Kaplan P; Ho SM
    Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
    Ho SM; Yu M
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone, and testosterone plus estrogen, in the castrated rat ventral prostate--histopathological and immunocytochemical studies.
    Murakoshi M; Tagawa M; Inada R; Suzuki M
    Tokai J Exp Clin Med; 1992 Oct; 17(3-4):133-7. PubMed ID: 1284451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
    Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D
    J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
    Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
    Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
    Yu M; Cates J; Leav I; Ho SM
    J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
    Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM
    Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats.
    Tam NN; Ghatak S; Ho SM
    Prostate; 2003 Apr; 55(1):1-8. PubMed ID: 12640655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats.
    Leav I; Merk FB; Kwan PW; Ho SM
    Prostate; 1989; 15(1):23-40. PubMed ID: 2477830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
    Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
    Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of glutathione-peroxidase and androgen receptors in the rat dorsolateral prostate.
    Murakoshi M; Tagawa M; Inada R; Mizokami A; Suzuki M; Watanabe K
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):87-94. PubMed ID: 7701534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
    Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
    Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
    Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M
    Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prostate growth stimulation by progesterone is due to androgenic products and progesterone receptor-mediated mechanisms.
    Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
    Pharmazie; 2009 Sep; 64(9):587-9. PubMed ID: 19827300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.